The North American journal Medicine, specialized in research articles in medical scientific disciplines and subspecialties, has recently published the clinical case of Repigment12.
The scientific journal Medicine, through an expert committee, certifies the scientific, technical, and ethical validity of the studies conducted and ensures compliance with high-quality standards. In addition, the journal endorses the clinical case presented by Lullage laboratories and Dr Matteo Bordignon, demonstrating the effectiveness of Repigment12.
Repigment12 is the result of more than 4 years of collaboration between Lullage laboratories and Dr Matteo Bordignon, an Italian dermatologist specializing in vitiligo. In May 2021, it was launched as the first cosmetic product for white spots by Lullage.
